Atlas FDA

Belotero Balance(+) Lidocaine Dermal Filler (BBL)

FDA premarket approval P090016/S060 · decided 2024-07-05

Approval details

PMA number
P090016
Supplement
S060
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Belotero Balance(+) Lidocaine Dermal Filler (BBL)
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2024-06-14
Decision date
2024-07-05
Days to decision
21 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Addition of an alternative, semi-automated process for secondary packaging of Belotero Balance (+) Lidocaine Dermal Filler in the SyringeOneconfiguration.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29